Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells
Authors
Keywords
-
Journal
Biomed Research International
Volume 2019, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2019-06-24
DOI
10.1155/2019/9241769
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EMT and inflammation: inseparable actors of cancer progression
- (2017) Meggy Suarez-Carmona et al. Molecular Oncology
- Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism
- (2017) Ting Ni et al. Cell Death & Disease
- NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo
- (2017) Xiaolu Cui et al. Scientific Reports
- GSK-3 inhibition overcomes chemoresistance in human breast cancer
- (2016) Andrey Ugolkov et al. CANCER LETTERS
- Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer
- (2016) Dongwu Liu et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Overview of Oroxylin A: A Promising Flavonoid Compound
- (2016) Lu Lu et al. PHYTOTHERAPY RESEARCH
- Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization
- (2015) L Wei et al. Cell Death & Disease
- Changing Treatment Paradigms in Metastatic Breast Cancer
- (2015) Cesar A. Santa-Maria et al. JAMA Oncology
- Oroxylin a prevents inflammation-related tumor through down-regulation of inflammatory gene expression by inhibiting NF-κB signaling
- (2012) Jing Yao et al. MOLECULAR CARCINOGENESIS
- Oroxylin-A Rescues LPS-Induced Acute Lung Injury via Regulation of NF-κB Signaling Pathway in Rodents
- (2012) Tzu-Ling Tseng et al. PLoS One
- Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway
- (2012) Zhijian Lu et al. TOXICOLOGY LETTERS
- Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
- (2010) Ana Bosch et al. CANCER TREATMENT REVIEWS
- L1CAM–integrin interaction induces constitutive NF-κB activation in pancreatic adenocarcinoma cells by enhancing IL-1β expression
- (2010) H Kiefel et al. ONCOGENE
- Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation
- (2009) Ying Gao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice
- (2009) M. A. Warren et al. MOLECULAR CANCER THERAPEUTICS
- Involvement of p53 in oroxylin A-induced apoptosis in cancer cells
- (2009) Rong Mu et al. MOLECULAR CARCINOGENESIS
- NF- B as a Critical Link Between Inflammation and Cancer
- (2009) M. Karin Cold Spring Harbor Perspectives in Biology
- Advances in Targeting IKK and IKK-Related Kinases for Cancer Therapy
- (2008) D.-F. Lee et al. CLINICAL CANCER RESEARCH
- Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells
- (2008) Yu Sun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search